Lv11
70 积分 2024-10-26 加入
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
3小时前
已完结
Positive EGFR mutation status is a risk of recurrence in pN0–1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis
2个月前
已完结
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2个月前
已完结
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives
3个月前
已完结
Facts and hopes in neoadjuvant immunotherapy combinations in resectable non-small-cell lung cancer
3个月前
已完结
Age-dependent genomic characteristics and their impact on immunotherapy in lung adenocarcinoma
4个月前
已完结
Radiomics and Deep Learning to Predict Pulmonary Nodule Metastasis at CT
5个月前
已完结
皖公网安备34019202002308
